Published: 2017-01-16

Comparative study of various intra ocular lens formulae by IOL master

Arikeri Krishna Kishore, Kuruva Nandyala Sree Kavitha, Peram Venkata Ratnam, Yenugandula Raman, Balaka Bala Krishna, Murahari Vijaya Keerthi


Background: The aim and objective of the study was to calculate intraocular lens power with IOL master in 100 eyes of 100 patients with long axial lengths between 25mm to 32mm.To analyse and compare the results of various formulae by postoperative auto refractometry and corrected distance visual acuity and to know the most accurate formula for highly myopic eyes (Axial length more than 25.00 mm).

Methods: Patients coming to Sarojini Devi Eye Hospital from December 2012-September 2014 for cataract surgery were considered in this study. All patients with visually significant cataract having fundus findings within normal limits were included in this study and patients of complicated cataract due to trauma, uveitis, Glaucoma and any corneal pathology were excluded from the study.

Results: The Mean AL was 27.25 ± 1.25 mm, the Mean keratometric value was 43.62 ± 1.45 D, and the Mean Absolute Error (MAE) calculated by the Haigis was 0.07 DD. Compared to the MAEs generated by the other formulae, the MAE generated by the Haigis was comparable to that by the SRK/T (0.231 D), and significantly lower than those by the Hoffer Q (0.481 D) and Holladay (0.864 D).

Conclusions: The Mean post-operative refractive error (spherical equivalent) was found to be the least with Haigis formula followed by SRK/T for eyes with long axial length.

The HAIGIS formula has a better predictability and accuracy. The postoperative hyperopic shift was comparable between HAIGIS and SRK-T formulae the least postoperative hyperopic shift with Haigis formula compared to other formulae.



Haigis, SRK-T, Holladay

Full Text:



Fanning A. Tuberculosis. extrapulmonary disease. CMAJ. 1999;160:1597-603.

Iscman MD. Tuberculosis in relation to human immunodeficiency virus and acquired immunodeficiency syndrome. In: Iseman MD, editor. A clinician’s guide to tuberculosis. Philadelphia: Lippincott Williams and Wilkins. 2000:199-252.

Dutt AK, Stead WW. Epidemiology. In: Schlossberg D, editor. Tuberculois and nontuberculous mycobacterial infection. Philadelphia: W.B. Saunders Company; 1999:3-16.

Indian Journal of Tuberculosis. Indian J Tuberc 2007;54:165-7.

Wares F, Balasubramanian R, Mohan A. Extra Pulmonary Tuberculosis, Management and Control. In: Fraser Wares, R. Balasubramanian, A. Mohan and S.K. Sharma, ed S.P. Agarwal and L. S. Chauhan’s Tuberculosis Control in India; Elsevier. 2005:95-114.

TB India 2007- RNTCP status Report. Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Nirman Bhawan, New Delhi, 2007.

Arora VK, Gupta Rajnish. Trends of EPTB under Revised National TB Control Programme: A study from South Delhi. Indian J Tuberc. 2006;53:77-83.

Arora VK, Gupta R. Directly observed treatment for tuberculosis. Indian J Paedtr. Fanning A. Tuberculosis. Extrapulmonary disease. CMAJ. 1999;160:1597-603.

Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization, 1997.

Sharma SK, Mohan A. Extrapulmonary tuberculosis. Indian J Med Res. 2004;120:316-53.

Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, et al. Identification of risk factors for extra pulmonary tuberculosis. Clin Infect Dis. 2004;38:199-205.

Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2002;6:879-86.

Musellim B, Erturan S, Sonmez Duman E, Ongen G. Comparison of extra-pulmonary and pulmonary tuberculosis cases: Factors influencing the site of reactivation. Int J Tuberc Lung Dis. 2005;9:1220-3.

Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extra pulmonary tuberculosis: Clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435-41.

Rama Prakasha S, Suresh G, Ganesh Kumar S. Mapping the Pattern and Trends of Extrapulmonary Tuberculosis. J Glob Infect Dis. 2013;5(2):54-9.

Özvaran MK, Baran R, Tor M, Dilek I. Extrapulmonary tuberculosis in non-human immunodeficiency virus-infected adults in an endemic region Ann Thorac Med. 2007;2(3):118-21.

Humphries MJ, Lam WK, Teoh R. In: Lymph Node Tuberculosis in Clinical Tuberculosis. Davies PD, editor. London, UK: Chapman and Hall Medical. 1995:94-8.

Van Loenhout-Rooyackers JH, Laheij RJ, Richter C, Verbeek AL. Shortening the duration of treatment for cervical tuberculosis lymphadenitis. Eur Respir J. 2000;15:192.

Shiba N, Preeti NP. Diversities in presentations of extrapulmonary (United States), 2013.

Gonzalez OY, Adams G, Teeter LD, Bui TT, Musser JM, Graviss EA. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int J Tuberc Lung Dis. 2003;7:1178-85.

Ilgazli A, Boyaci H, Basyigit I, Yildiz F. Extrapulmonary tuberculosis: Clinical and epidemiologic spectrum of 636 cases. Arch Med Res. 2004;35:435-41.

Humphries MJ, Lam WK, Teoh R. In: Lymph Node Tuberculosis in Clinical Tuberculosis. Davies PD, editor. London, UK: Chapman and Hall Medical. 1995:94-8.

Maltezou HC, Spyridis P, Kafetzis DA. Extra-pulmonary tuberculosis in children. Arch Dis Child. 2000;83:342-6.

Uygur-Bayramiçli O, Dabak G, Dabak R. A clinical dilemma: Abdominal tuberculosis. World J Gastroenterol. 2003;9:1098-101.

Chennaveerappa PK, Siddharam SM, Halesha BR, Vittal BG, Jayashree N. Treatment outcome of tuberculosis patients registered at dots centre in a teaching hospital, South India. Int J Biol Med Res. 2011;2:487-9.